NTRA:NASDAQ
Natera Inc
US$408,47
arrow_downward
-1,17%(-4,84) 1D
US$408,47
0,00% (0,00)
bedtimeAfter hours
Closed: 1 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NTRA...
Open
US$413,31
High
US$423,43
Low
US$407,37
Mkt. cap
58,88 ຕື້
Avg. vol.
1,47 ລ້ານ
Volume
1,86 ລ້ານ
52-wk high
US$427,47
52-wk low
US$157,42
EPS
US$-1,37
Beta
1,54
Shares outstanding
144,14 ລ້ານ
No. of employees
6 ພັນ
Open
US$413,31
High
US$423,43
Low
US$407,37
Mkt. cap
58,88 ຕື້
Avg. vol.
1,47 ລ້ານ
Volume
1,86 ລ້ານ
52-wk high
US$427,47
52-wk low
US$157,42
EPS
US$-1,37
Beta
1,54
Shares outstanding
144,14 ລ້ານ
No. of employees
6 ພັນ
News stories
From web sources and news partners
Stock Titan
·
4 ຊົ່ວໂມງກ່ອນ
After five sales in three months, a Natera (NTRA) officer proposes another stock sale.
Profile
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
About Natera Inc
CEOSteven Chapman
Employees6,14 ພັນ
Founded1 ມ.ກ. 2004
Headquartersອອສຕິນ, ເທັກຊັສ, ສະຫະລັດ
SectorBiotechnology
Websitenatera.com